Suchergebnisse - "Solanich, Xavier"

PubPharm (53)

1

Diagnosis and clinical management of thrombotic thrombocytopenic purpura (TTP) : a consensus statement from the TTP Catalan group

enthalten in: Blood transfusion = Trasfusione del sangue | 2024

von Muñoz, N. | Ortega, S. | Solanich, X. | +18

2

Single-cell multi-omics analysis of COVID-19 patients with pre-existing autoimmune diseases shows aberrant immune responses to infection

enthalten in: European journal of immunology | 2024

von Barmada, A. | Handfield, L. | Godoy-Tena, G. | +35

3

Vaccine breakthrough hypoxemic COVID-19 pneumonia in patients with auto-Abs neutralizing type I IFNs

enthalten in: Science immunology | 2023

von Bastard, P. | Vazquez, S. | Liu, J. | +98

4

Insights into the Value of Lyso-Gb1 as a Predictive Biomarker in Treatment-Naïve Patients with Gaucher Disease Type 1 in the LYSO-PROOF Study

enthalten in: Diagnostics (Basel, Switzerland) | 2023

von Curado, F. | Rösner, S. | Zielke, S. | +43

5

enthalten in: Medicina clinica | 2023

von Rocamora-Blanch, G. | Climent, F. | Solanich, X.

6

Three-Day Icatibant on Top of Standard Care in Patients With Coronavirus Disease 2019 Pneumonia : A Randomized, Open-Label, Phase 2, Proof-of-Concept Trial

enthalten in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America | 2023

von Malchair, P. | Giol, J. | García, V. | +15

CommentIn: Infect Dis (Lond). 2023 Jun;55(6):444-445. - PMID 37067851

7

The risk of COVID-19 death is much greater and age-dependent with type I IFN autoantibodies

enthalten in: ResearchSquare.com | 2022

von Manry, J. | Bastard, P. | Gervais, A. | +177

8

A multicenter, open-label, randomized, proof-of-concept phase II clinical trial to assess the efficacy and safety of icatibant in patients infected with SARS-CoV-2 (COVID-19) and admitted to hospital units without invasive mechanical ventilation : study protocol (ICAT-COVID)

enthalten in: Trials | 2022

von Malchair, P. | Otero, A. | Giol, J. | +34

9

A multicenter, open-label, randomized, proof-of-concept phase II clinical trial to assess the efficacy and safety of icatibant in patients infected with SARS-CoV-2 (COVID-19) and admitted to hospital units without invasive mechanical ventilation: study protocol (ICAT-COVID)

enthalten in: Trials | 2022

von Malchair, P. | Otero, A. | Giol, J. | +7

10

A multicenter, open-label, randomized, proof-of-concept phase II clinical trial to assess the efficacy and safety of icatibant in patients infected with SARS-CoV-2 (COVID-19) and admitted to hospital units without invasive mechanical ventilation: study protocol (ICAT-COVID)

enthalten in: Trials | 2022

von Malchair, P. | Otero, A. | Giol, J. | +7

1
2
3
4
5
6
Nächster »
[6]